VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

376-1667-00L 4 Credits DR , MSC D-HEST , D-BSSE , D-CHAB

Drug Development: From Bench to Bedside

Lecturers & Examiners: Dr. Collin Ewald, Dr. Markus Kalousek
VVZ CR n/a

Last Updated: 2026-06-03 00:14:08

Abstract

This lecture will provide a holistic understanding of how various scientific disciplines are applied to develop a new drug which addresses the unmet needs of patients, physicians, regulators and payers.Emphasis on interdependencies between disciplines and development phases, with real life industry examples. Includes a small case study (Übung)

Objective

-Understand the key steps of drug development and their interdependencies -Be aware of VC funding options; extrapolate the commercial attractiveness of a startup idea based on Mechanism of Action and competitive environment -Facilitate transition into the Biotech & Pharma industry

Content

- Project planning - start with the end in mind - Define unmet needs of key customer segments - Disease Biology, Mechanism of Action and its translation into patient benefits - Drug design, formulation, manufacturing and upscaling - Toxicology - Pharmacokinetics & Pharmacodynamics - Translational Medicine - Clinical development - Connecting the dots between all of above - Regulatory strategy - Patents / IP - Market access & pricing - How to project potential patient (and commercial) value of projects - Obtaining funding from VCs

Resources

Literature

Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments Hardcover, 2022. ISBN-13 978-3527345717 Markus Hinder et al

General Information

Language
English
Levels
DR , MSC
Frequency
Yearly recurring

Examination

Type
graded semester performance

Course Components

Type Title Time & Place Hours
lecture with exercise Drug Development: From Bench to Bedside
  • Thu 08:15-10:00 (HG D 5.2)
2 h weekly

Offered In